miR-31 promotes proliferation of colon cancer cells by targeting E2F2

被引:0
|
作者
Tong Li
Wenjing Luo
Kunmei Liu
Xiaobo Lv
Tao Xi
机构
[1] China Pharmaceutical University,School of Life Science and Technology
[2] China Pharmaceutical University,Jiangsu Key Laboratory of Carcinogenesis and Intervention
[3] Ningxia Medical University,Ningxia Key Laboratory of Cerebrocranial Diseases
来源
Biotechnology Letters | 2015年 / 37卷
关键词
Anti-cancer drug design; Colon cancer cells; E2F2; MicroRNA-31; Proliferation; Survivin; Tumor suppression;
D O I
暂无
中图分类号
学科分类号
摘要
MicroRNA-31 (miR-31) plays important roles in colon cancer development. However, the underlying mechanism is still not clear. We have explored the functions of miR-31 on proliferation of colon cancer cells as well as the underlying mechanism. E2F2 was identified as a direct target of miR-31. miR-31 regulated the proliferation of colon cancer cells by targeting E2F2. Moreover, in the present study, E2F2 acted as a tumor suppressor in colon cancer by repressing the expression of survivin and regulating the expression of CCNA2, C-MYC, MCM4 and CDK2. A possible mechanism for the function of miR-31 on colon cancer proliferation is presented and indicates that miR-31 might become a target for anti-cancer drug design.
引用
收藏
页码:523 / 532
页数:9
相关论文
共 50 条
  • [21] CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis
    Li, Zhengwen
    Cai, Xiaojing
    Zou, Wentao
    Zhang, Jiaxiong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 13406 - 13422
  • [22] miR-31 inhibits cell proliferation and invasion through targeting ROCK1 in prostate cancer
    Zhang, Wenbin
    Zhou, Jin
    Wu, Wenfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2908 - 2916
  • [23] E2F2 Suppresses Myc-Induced Proliferation and Tumorigenesis
    Pusapati, Raju V.
    Weaks, Regina L.
    Rounbehler, Robert J.
    McArthur, Mark J.
    Johnson, David G.
    MOLECULAR CARCINOGENESIS, 2010, 49 (02) : 152 - 156
  • [24] MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer
    Luo, Long-ji
    Yang, Fan
    Ding, Jia-ji
    Yan, Da-li
    Wang, Dan-dan
    Yang, Su-jin
    Ding, Li
    Li, Jian
    Chen, Dan
    Ma, Rong
    Wu, Jian-zhong
    Tang, Jin-hai
    GENE, 2016, 594 (01) : 47 - 58
  • [25] Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells
    Iwasaki, Tatsuya
    Tanaka, Kazuhiro
    Kawano, Masanori
    Itonaga, Ichiro
    Tsumura, Hiroshi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (04) : 1543 - 1550
  • [26] miR-1245a promotes the proliferation and invasion of colon adenocarcinoma by targeting BRCA2
    Pan, Zihao
    Gan, Wenchang
    Liang, Caiqian
    Xiao, Yuanxun
    Zhang, Yu
    Yang, Weisheng
    Hou, Zehui
    Chen, Shuang
    Zeng, Bing
    Li, Yingru
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [27] MiR-31 promotes Th22 differentiation through targeting Bach2 in coronary heart disease
    Huang, Rimao
    Chen, Xuliang
    Long, Yadong
    Chen, Ri
    BIOSCIENCE REPORTS, 2019, 39
  • [28] MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer
    Li, Maolan
    Chen, Wei
    Zhang, Hongchen
    Zhang, Yong
    Ke, Fayong
    Wu, Xiangsong
    Zhang, Yijian
    Weng, Mingzhe
    Liu, Yingbin
    Gong, Wei
    ONCOTARGET, 2016, 7 (50) : 83060 - 83070
  • [29] Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA
    Chang, Kuo-Wei
    Kao, Shou-Yen
    Wu, Yi-Hsuan
    Tsai, Meng-Miao
    Tu, Hsi-Feng
    Liu, Chung-Ji
    Lui, Mann-Tin
    Lin, Shu-Chun
    ORAL ONCOLOGY, 2013, 49 (01) : 27 - 33
  • [30] LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis
    Li, Zhen
    Lang, Zhiqiang
    Wang, Ting
    Qu, Guimei
    Sui, Wu
    Liu, Jing
    CELL CYCLE, 2023, 22 (03) : 347 - 360